Stay updated with breaking news from Carter bir. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com assumed coverage on shares of Reata Pharmaceuticals (NASDAQ:RETA – Free Report) in a research report released on Tuesday. The firm issued a sell rating on the stock. A number of other analysts have also recently weighed in on the stock. 888 restated a reiterates rating on shares of Reata Pharmaceuticals in a research note […] ....
Short Interest in Reata Pharmaceuticals, Inc. (NASDAQ:RETA) Decreases By 38.1% kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.
StockNews.com started coverage on shares of Reata Pharmaceuticals (NASDAQ:RETA – Free Report) in a research note released on Friday morning. The firm issued a sell rating on the stock. RETA has been the topic of a number of other research reports. Jefferies Financial Group downgraded Reata Pharmaceuticals from a buy rating to a hold rating […] ....
StockNews.com initiated coverage on shares of Reata Pharmaceuticals (NASDAQ:RETA – Free Report) in a research report released on Friday morning. The brokerage issued a sell rating on the stock. Other research analysts also recently issued research reports about the stock. Stifel Nicolaus downgraded shares of Reata Pharmaceuticals from a buy rating to a hold rating […] ....
Reata Pharmaceuticals, Inc. (NASDAQ:RETA – Get Free Report) reached a new 52-week high on Monday . The company traded as high as $170.83 and last traded at $170.83, with a volume of 25211 shares traded. The stock had previously closed at $170.32. Analysts Set New Price Targets A number of research firms have weighed in […] ....